FLUIDIGM CORP Contracts & Agreements

2024 Change of Control and Severance Plan and Participation Agreement (Filed With SEC on August 30, 2024)

Standard BioTools Inc. Nonemployee Director Compensation Policy (Filed With SEC on August 6, 2024)

Standard BioTools Inc. Amended and Restated 2011 Equity Incentive Plan, As Amended (Filed With SEC on July 1, 2024)

Exchange Agreement, dated March 18, 2024, by and between Standard BioTools Inc. and the Investors (Filed With SEC on March 18, 2024)

Description of Securities (Filed With SEC on March 1, 2024)

Form of Indemnification Agreement entered into by and between Standard BioTools Inc. and certain of its officers and directors (Filed With SEC on March 1, 2024)

Standard BioTools Inc. Amended and Restated Outside Director Equity Compensation Policy (Filed With SEC on March 1, 2024)

Standard BioTools Inc. Amended and Restated 2011 Equity Incentive Plan (Filed With SEC on January 5, 2024)

Offer letter, by and between Standard BioTools Inc. and Adam Taich, dated as of October 1, 2023 (Filed With SEC on November 14, 2023)

2023 Change of Control and Severance Plan Participation Agreement, by and between Standard BioTools Inc. and Hanjoon Alex Kim, dated July 24, 2023 (Filed With SEC on August 8, 2023)

Offer letter, by and between Standard BioTools Inc. and Jeremy Davis, dated April 4, 2023 (Filed With SEC on August 8, 2023)

2023 Change of Control and Severance Plan Participation Agreement, by and between Standard BioTools Inc. and Jeremy Davis, dated June 28, 2023 (Filed With SEC on August 8, 2023)

2023 Change of Control and Severance Plan (Filed With SEC on July 28, 2023)

Form of PSU Award Agreement (Filed With SEC on July 28, 2023)

Standard BioTools Inc. Amended and Restated 2011 Equity Incentive Plan (Filed With SEC on June 16, 2023)

Offer letter by and between Standard BioTools Inc. and Jeffery G. Black executed May 10, 2023 (Filed With SEC on May 15, 2023)

Standard BioTools Inc. 2020 Change of Control and Severance Plan Participation Agreement by and between Jeffery G. Black and Standard BioTools Inc. dated May 10, 2023 (Filed With SEC on May 15, 2023)

Letter agreement by and between Standard BioTools Inc. and Vikram Jog dated May 10, 2023 (Filed With SEC on May 15, 2023)

Sublease, dated as of August 30, 2022, between Standard BioTools Inc. and CIRC Bio, Inc (Filed With SEC on November 9, 2022)

Support Agreement, dated March 29, 2022, by and among Fluidigm Corporation and Caligan Partners LP and certain of its affiliates (Filed With SEC on March 29, 2022)

Letter Agreement dated March 25, 2022 (Filed With SEC on March 28, 2022)

Lease Agreement dated December 13, 2021 between Fluidigm Singapore Pte. Ltd. and HSBC Institutional Trust Services (Singapore) Limited as Trustee of Ascendas Real Estate... (Filed With SEC on March 8, 2022)

Fifth Amendment to Loan and Security Agreement, dated December 27, 2021, between the Company and Silicon Valley Bank (Filed With SEC on March 8, 2022)

Default Waiver and Consent to Loan and Security Agreement, dated March 4, 2022, between the Company and Silicon Valley Bank (Filed With SEC on March 8, 2022)

Series B-1 Loan Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Casdin Partners Master Fund, L.P., and Casdin Private Growth Equity Fund II, L.P (Filed With SEC on February 11, 2022)

Series B-1 Loan Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Casdin Partners Master Fund, L.P., and Casdin Private Growth Equity Fund II, L.P (Filed With SEC on January 24, 2022)

Series B-2 Loan Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments Sub-Master LP, and Viking Global... (Filed With SEC on January 24, 2022)

Series B-1 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., and Casdin... (Filed With SEC on January 24, 2022)

Series B-2 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments... (Filed With SEC on January 24, 2022)

Registration Rights Agreement, dated as of January 23, 2022, by and between Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., Casdin Partners Master Fund, L.P.,... (Filed With SEC on January 24, 2022)

Stephen Christopher Linthwaite Transition Agreement and Release (Filed With SEC on January 24, 2022)

Michael Egholm Offer Letter (Filed With SEC on January 24, 2022)

Indemnification Agreement, dated January 23, 2022, by and between Fluidigm Corporation and Michael Egholm (Filed With SEC on January 24, 2022)

Hanjoon Alex Kim Offer Letter (Filed With SEC on January 24, 2022)

Form of Retention Letter (Filed With SEC on January 24, 2022)

Amendment dated (Filed With SEC on November 9, 2021)

Amendment dated May 10, 2021 to (Filed With SEC on August 6, 2021)

Lease Agreement dated November 19, 2020 between Fluidigm Singapore Pte. Ltd. and HSBC Institutional Trust Services (Singapore) Limited as Trustee of Ascendas Real Estate... (Filed With SEC on August 6, 2021)

Lease Agreement dated June 8, 2021 between Fluidigm Singapore Pte. Ltd. and HSBC Institutional Trust Services (Singapore) Limited as Trustee of Ascendas Real Estate Investment... (Filed With SEC on August 6, 2021)

Repatriation Agreement with Colin McCracken dated June 16, 2021 (Filed With SEC on August 6, 2021)

Terms and Conditions of Employment for Colin McCracken, effective June 26, 2021 (Filed With SEC on August 6, 2021)

Fourth Amendment to Loan and Security Agreement, dated as of August 2, 2021, between Fluidigm Corporation and Silicon Valley Bank (Filed With SEC on August 5, 2021)

Fluidigm Corporation 2011 Equity Incentive Plan, as amended effective May 25, 2021 (Filed With SEC on May 25, 2021)

Contract by and between the National Institutes of Health and the registrant effective as of July 30, 2020, as amended September 28, 2020 (Filed With SEC on May 7, 2021)

Description of Securities (Filed With SEC on February 25, 2021)

Second Amendment to Lease between AP3-SF3 CT North, LLC and Fluidigm Corporation, dated February 25, 2020 (Filed With SEC on February 25, 2021)

Offer Letter to Colin McCracken dated April 12, 2019 (Filed With SEC on February 25, 2021)

Offer Letter to Nick Khadder dated April 6, 2020 (Filed With SEC on February 25, 2021)

Contract by and between the National Institutes of Health and the (Filed With SEC on November 9, 2020)

Second Amended and Restated License Agreement between California Institute of Technology and the registrant effective as of May 1, 2004 (Filed With SEC on November 9, 2020)

First Addendum, effective as of March 29, 2007, to Second Amended and Restated License Agreement between California Institute of Technology and the registrant effective as of May... (Filed With SEC on November 9, 2020)

Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000 (Filed With SEC on November 9, 2020)

First Amendment to Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000 (Filed With SEC on November 9, 2020)

Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000 (Filed With SEC on November 9, 2020)

Letter Agreement between President and Fellows of Harvard College and the registrant dated December 22, 2004 (Filed With SEC on November 9, 2020)

Fluidigm Corporation 2020 Change of Control and Severance Plan (Filed With SEC on August 7, 2020)

Fluidigm Corporation 2017 Employee Stock Purchase Plan, as amended and restated effective June 23, 2020 (Filed With SEC on June 24, 2020)

Fluidigm Corporation 2011 Equity Incentive Plan, as amended effective June 23, 2020 (Filed With SEC on June 24, 2020)

Third Amendment to Loan and Security Agreement, dated April 21, 2020, between the Company and Silicon Valley Bank (Filed With SEC on April 22, 2020)

Open Market Sale AgreementSM, dated as of March 4, 2020, between Fluidigm Corporation and Jefferies LLC (Filed With SEC on March 5, 2020)

Description of Securities (Filed With SEC on February 27, 2020)

Default Waiver and First Amendment to Loan and Security Agreement, dated September 1, 2018, between the Company and Silicon Valley Bank (Filed With SEC on February 27, 2020)

Purchase Agreement, dated November 20, 2019, between Fluidigm Corporation and Barclays Capital Inc., as representative of the several initial purchasers named in Schedule I thereto (Filed With SEC on November 22, 2019)

Second Amendment to Loan and Security Agreement, dated November 20, 2019, between the Company and Silicon Valley Bank (Filed With SEC on November 22, 2019)

Indenture, dated November 22, 2019, between Fluidigm Corporation and U.S. Bank National Association (Filed With SEC on November 22, 2019)

Tenth Amendment to Lease Agreement between ARE-San Francisco No. 17, LLC and Fluidigm Corporation, dated August 14, 2019 (Filed With SEC on November 8, 2019)

Amended and Restated 2011 Equity Incentive Plan (Filed With SEC on June 5, 2019)

First Amendment to Lease between AP3-SF3 CT North, LLC and Fluidigm Corporation, dated April 26, 2019 (Filed With SEC on May 7, 2019)

Lease between AP3-SF3 CT North, LLC and Fluidigm Corporation, dated March 20, 2019 (Filed With SEC on May 7, 2019)

Offer Letter to Bradley A. Kreger dated February 13, 2018 (Filed With SEC on March 18, 2019)

Purchase Agreement, dated December 11, 2018 (Filed With SEC on December 12, 2018)

Form of Retention Bonus Exchange Letter (Filed With SEC on September 20, 2018)

Ninth Amendment to Lease between ARE-San Francisco No. 17, LLC and Fluidigm Corporation, dated May 31, 2018 (Filed With SEC on August 8, 2018)

Loan and Security Agreement, dated as of August 2, 2018, by and between Fluidigm Corporation and Silicon Valley Bank (Filed With SEC on August 2, 2018)

Offer Letter to Chris Linthwaite, dated as of July 14, 2016 (Filed With SEC on May 8, 2018)

Second Supplemental Indenture, dated March 6, 2018, between the Company and U.S. Bank National Association (Filed With SEC on March 6, 2018)

Endorsement Split-Dollar Life Insurance Agreement (Filed With SEC on November 7, 2017)

FLUIDIGM CORPORATION CHANGE OF CONTROL AND SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION (Filed With SEC on August 23, 2017)

Fluidigm Corporation $30.0MILLION COMMON STOCK SALES AGREEMENT (Filed With SEC on August 3, 2017)

EIGHTH AMENDMENT TO LEASE (Filed With SEC on August 3, 2017)

FLUIDIGM CORPORATION 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 2, 2017)

AMENDMENTS TO EQUITY COMPENSATION PLANS (Filed With SEC on August 2, 2017)

SEVENTH AMENDMENT TO LEASE (Filed With SEC on May 9, 2017)

FLUIDIGM CORPORATION 2017 INDUCEMENT AWARD PLAN (Filed With SEC on January 11, 2017)

TAX BENEFIT PRESERVATION PLAN Dated as of November 21, 2016 by and between FLUIDIGM CORPORATION and COMPUTERSHAREINC., as Rights Agent TABLE OF CONTENTS (Filed With SEC on November 22, 2016)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 9, 2016)

FLUIDIGM CORPORATION EMPLOYMENT AND SEVERANCE AGREEMENT (Filed With SEC on November 9, 2016)

SIXTH AMENDMENT TO LEASE (Filed With SEC on December 14, 2015)

OFFICE LEASE RODICK EQUITIES INC. (Landlord) - and - FLUIDIGM CANADA INC. (Tenant) - and - FLUIDIGM CORPORATION (Indemnifier) SUITES 400 AND 401 ON THE FOURTH FLOOR OF THE OFFICE... (Filed With SEC on November 9, 2015)

ascendas.com (Filed With SEC on August 10, 2015)

FIFTH AMENDMENT TO LEASE (Filed With SEC on November 6, 2014)

BUSINESS FINANCING MODIFICATION AND WAIVER AGREEMENT (Filed With SEC on August 4, 2014)

FOURTH AMENDMENT TO LEASE (Filed With SEC on August 4, 2014)

LICENSE AGREEMENT (Filed With SEC on May 12, 2014)

SUBLICENSE AGREEMENT (Filed With SEC on May 12, 2014)

BUSINESS FINANCING MODIFICATION AND WAIVER AGREEMENT (Filed With SEC on May 12, 2014)

Monthly Service Charge (Filed With SEC on March 12, 2014)

Indenture FLUIDIGM CORPORATION,as ISSUER and U.S. BANK NATIONAL ASSOCIATION, as INDENTURE TRUSTEE INDENTURE Dated as of February 4, 2014 TABLE OF CONTENTS (Filed With SEC on February 4, 2014)

FLUIDIGM CORPORATION, as ISSUER and U.S. BANK NATIONAL ASSOCIATION, as Trustee FIRSTSUPPLEMENTAL INDENTURE DATED AS OF FEBRUARY 4, 2014 TO INDENTURE DATED ASOF FEBRUARY 4, 2014... (Filed With SEC on February 4, 2014)

UNDERWRITING AGREEMENT 2.75%Convertible Senior Notes due 2034 Fluidigm Corporation Common Stock ($0.001 Par Value) January 29, 2014 (Filed With SEC on January 30, 2014)

AGREEMENT AND PLAN OF MERGER by and among DVSSCIENCES, INC., FLUIDIGM CORPORATION, DAWID MERGER SUB, INC. and SHAREHOLDERREPRESENTATIVE SERVICES LLC, solely in its capacity as the... (Filed With SEC on January 29, 2014)

BUSINESS FINANCING MODIFICATION AGREEMENT (Filed With SEC on January 29, 2014)

SECOND AMENDMENT TO LEASE (Filed With SEC on May 9, 2013)

BUSINESS FINANCING MODIFICATION AGREEMENT (Filed With SEC on December 27, 2012)

FLUIDIGM CORPORATION AMENDED AND RESTATED EMPLOYMENT AND SEVERANCE AGREEMENT (Filed With SEC on December 11, 2012)

UNDERWRITING AGREEMENT FOR EQUITY OFFERING 3,660,000 Shares Fluidigm Corporation Common Stock ($0.001 Par Value) August 16, 2012 (Filed With SEC on August 16, 2012)

BUSINESS FINANCING MODIFICATION AGREEMENT (Filed With SEC on April 4, 2011)

FluidigmCorporation 7000 Shoreline Court, Suite 100, South San Francisco, California 94080 tel ###-###-#### fax: 650 ###-###-#### www.fluidigm.com (Filed With SEC on April 4, 2011)

CONFIDENTIAL TREATMENT REQUESTED BY FLUIDIGM CORPORATION Amendment #1to the Collaboration and Option Agreement dated May 17, 2010 By and between Fluidigm Corporation and Novartis... (Filed With SEC on April 4, 2011)

FLUIDIGM CORPORATION EXECUTIVE BONUS PLAN Adopted: March 22, 2011 (Filed With SEC on March 28, 2011)

COLLABORATION AND OPTION AGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION DATE: MAY 17, 2010 (Filed With SEC on February 9, 2011)

FORM OF UNDERWRITING AGREEMENT FOR EQUITY OFFERING 5,172,414 Shares Fluidigm Corporation Common Stock ($0.001 Par Value) February , 2011 (Filed With SEC on February 7, 2011)

COLLABORATION AND OPTION AGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION DATE: MAY 17, 2010 (Filed With SEC on February 2, 2011)

CONFIDENTIAL TREATMENT REQUESTED BY FLUIDIGM CORPORATION LICENSEAGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION DATE: [ ] (Filed With SEC on February 2, 2011)

QUALITYAGREEMENT FOR DEVELOPMENT OF IN-VITRO DIAGNOSTICS DEVICES Between Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street, Emeryville, CA 94608 subsequently referred to... (Filed With SEC on February 2, 2011)

BUSINESS FINANCING AGREEMENT (Filed With SEC on January 28, 2011)

FLUIDIGM CORPORATION INDEMNIFICATION AGREEMENT (Filed With SEC on January 28, 2011)

FLUIDIGM CORPORATION 2011 EQUITY INCENTIVE PLAN Adopted and approved January 20, 2011 and effective as of the Companys initial public offering. (Filed With SEC on January 28, 2011)

FLUIDIGM CORPORATION 2011 EQUITY INCENTIVE PLAN NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on January 28, 2011)

4060.LICI.006 Harvard CO-EXCLUSIVE LICENSE AGREEMENT Between President and Fellows of Harvard College And Mycometrix Corporation Effective as of October 15, 2000 Re: Harvard Case... (Filed With SEC on January 28, 2011)

COLLABORATIONAND OPTION AGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION DATE: MAY 17, 2010 (Filed With SEC on January 18, 2011)

LICENSEAGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION Date: [ ] (Filed With SEC on January 18, 2011)

QUALITYAGREEMENT FOR DEVELOPMENT OF IN-VITRO DIAGNOSTICS DEVICES Between Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street, Emeryville, CA 94608 subsequently referred to... (Filed With SEC on January 18, 2011)

FLUIDIGM CORPORATION and 454 LIFE SCIENCES, A ROCHE COMPANY CO-PROMOTION AGREEMENT (Filed With SEC on January 18, 2011)

FLUIDIGM CORPORATION NINTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 16, 2009 TABLE OF CONTENTS (Filed With SEC on January 7, 2011)

NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 7, 2011)

LEASE AGREEMENT (Filed With SEC on January 7, 2011)

5,300,000 SHARES (Filed With SEC on September 15, 2008)

Shares (Filed With SEC on September 15, 2008)

FLUIDIGM CORPORATION (Filed With SEC on September 15, 2008)

Loanand Security Agreements (Filed With SEC on September 15, 2008)

Fluidigm Corporation a California corporation (Filed With SEC on September 15, 2008)

PATENT LICENSE AGREEMENT 3950.LICI.001 Gyros AB (Filed With SEC on September 15, 2008)

MASTER CLOSING AGREEMENT By and Among FLUIDIGM CORPORATION, a California corporation, OCULUS PHARMACEUTICALS, INC., a Delaware corporation, and THE UAB RESEARCH FOUNDATION dated... (Filed With SEC on September 15, 2008)

PROJECT MILESTONES AND DELIVERABLES (Filed With SEC on September 15, 2008)

Distribution Agreement (Filed With SEC on September 15, 2008)

HARVARD UNIVERSITY Office for Technology and Trademark Licensing Holyoke Center, Suite ###-###-#### Massachusetts Avenue Cambridge, MA 02138 USA t. 617 ###-###-#### f. 617... (Filed With SEC on September 15, 2008)

SUBLEASE (Filed With SEC on September 15, 2008)

EXHIBIT 10.3A (Filed With SEC on September 5, 2008)

EXHIBIT 10.12A (Filed With SEC on August 27, 2008)

FLUIDIGM CORPORATION (Filed With SEC on August 13, 2008)

Loanand Security Agreements (Filed With SEC on August 13, 2008)

4060.LICI.006 Harvard Co-Exclusive License Agreement Between President and Fellows of Harvard College And Mycometrix Corporation Effective as of October 15, 2000 Re:Harvard Case... (Filed With SEC on August 13, 2008)

MASTER CLOSING AGREEMENT By and Among FLUIDIGM CORPORATION, a California corporation, OCULUS PHARMACEUTICALS, INC., a Delaware corporation, and THE UAB RESEARCH FOUNDATION dated... (Filed With SEC on August 13, 2008)

EMPLOYEE LOAN AGREEMENT (Filed With SEC on August 13, 2008)

Disruptive Technology. We believe we have achieved an unprecedented level of miniaturization in microfluidics, allowing us to integrate the components required to automate a broad... (Filed With SEC on May 27, 2008)

EXHIBIT 4.4A (Filed With SEC on April 14, 2008)

EXHIBIT 4.4B (Filed With SEC on April 14, 2008)

EXHIBIT 4.5A (Filed With SEC on April 14, 2008)

EXHIBIT 10.2A (Filed With SEC on April 14, 2008)

EXHIBIT 10.4A (Filed With SEC on April 14, 2008)

EXHIBIT 10.5A (Filed With SEC on April 14, 2008)

EXHIBIT 10.8A (Filed With SEC on April 14, 2008)

EXHIBIT 10.9A (Filed With SEC on April 14, 2008)

EXHIBIT 10.10A (Filed With SEC on April 14, 2008)

EXHIBIT 10.15A (Filed With SEC on April 14, 2008)

Disruptive and Enabling Technology. We believe our IFC systems overcome many of the limitations of conventional methods of laboratory research by integrating on a single device a... (Filed With SEC on April 14, 2008)

Category

Industry

Companies

Contracts

FLUIDIGM CORP Contracts & Agreements